Search

Your search keyword '"Carcinoma, Hepatocellular virology"' showing total 5,522 results

Search Constraints

Start Over You searched for: Descriptor "Carcinoma, Hepatocellular virology" Remove constraint Descriptor: "Carcinoma, Hepatocellular virology"
5,522 results on '"Carcinoma, Hepatocellular virology"'

Search Results

1. Unveiling novel prognostic biomarkers and therapeutic targets for HBV-associated hepatocellular carcinoma through integrated bioinformatic analysis.

2. Serum laminin γ2 monomer as a predictive biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection: a retrospective cohort study.

3. The loss of hepatitis B virus receptor NTCP/SLC10A1 in human liver cancer cells is due to epigenetic silencing.

4. Association of IL-6 G-174C (rs1800795) variant with the susceptibility to hepatocellular carcinoma in patients with chronic hepatitis.

5. Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122.

6. Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC.

7. DAA treatment for HCV reduce risk of hepatocellular carcinoma: a 10-years follow-up study based on Chinese patients with hepatitis C.

8. AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separation.

9. Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B: still needs further discussion.

10. Enhanced interactions within microenvironment accelerates dismal prognosis in HBV-related HCC after TACE.

11. Euphorbia helioscopia L. extract suppresses hepatitis B virus-related hepatocellular carcinoma via alpha serine/threonine-protein kinase and Caspase-3.

12. Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Development and External Validation of a New Prognostic Model.

13. Hepatitis C virus chronicity and oncogenic potential: Vaccine development progress.

14. The Influence of ESR2 Gene Polymorphisms on Susceptibility to Hepatitis B Virus-Related Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma.

15. Leptin receptor Gln223Arg and Lys109Arg polymorphisms may be associated with HBV-related hepatocellular carcinoma risk: A system review and meta-analysis.

16. SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma.

17. Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis.

18. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.

19. Gene Expression Aberrations in Alcohol-Associated Hepatocellular Carcinoma.

20. Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis.

21. Hepatitis C virus attributable liver cancer in the country of Georgia, 2015-2019: a case-control study.

22. Hepatitis B Virus X Protein Induces Reactive Oxygen Species Generation via Activation of p53 in Human Hepatoma Cells.

23. [Risk prediction model of hepatitis B associated hepatocellular carcinoma].

24. Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents.

25. Mechanism of emodin in treating hepatitis B virus-associated hepatocellular carcinoma: network pharmacology and cell experiments.

26. Advanced Prediction of Hepatic Oncogenic Transformation in HBV Patients via RNA-Seq Data Analysis and Deep Learning Techniques.

27. Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study.

28. USP26 as a hepatitis B virus-induced deubiquitinase primes hepatocellular carcinogenesis by epigenetic remodeling.

29. Hepatitis B Virus X Protein Represses Expression of Tumor Suppressor PTPN18 in Hepatocellular Carcinoma.

30. A nomogram model for early recurrence of HBV-related hepatocellular carcinomas after radical hepatectomy.

31. The trajectory of vesicular proteomic signatures from HBV-HCC by chitosan-magnetic bead-based separation and DIA-proteomic analysis.

32. Risk predictive model for the development of hepatocellular carcinoma before initiating long-term antiviral therapy in patients with chronic hepatitis B virus infection.

33. Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429-dependent m6A modification of CCR9.

34. Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.

35. Elevated Hepatitis B virus RNA levels in hepatocellular carcinoma patients compared to cirrhotic individuals: A propensity score matched analysis.

36. Impact of DAA Treatment for HCV on Hepatocellular Carcinoma in a Predominately African American Population.

37. Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International Network.

38. Current research insights into the role of CTLA-4 in hepatitis B virus (HBV) infection.

39. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort.

40. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.

41. AC099850.3 promotes HBV-HCC cell proliferation and invasion through regulating CD276: a novel strategy for sorafenib and immune checkpoint combination therapy.

42. lncRNA POLR2J4 Plays a Biomarker Role in Hepatitis B Virus-Related Hepatocellular Carcinoma Through Regulating miR-214-3p.

43. Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis.

44. Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity.

45. Screening and molecular docking verification of feature genes related to phospholipid metabolism in hepatocarcinoma caused by hepatitis B.

46. The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection.

47. First Detection of Hepatitis B Virus Subgenotype A5, and Characterization of Occult Infection and Hepatocellular Carcinoma-Related Mutations in Latin American and African Immigrants in Brazil.

48. Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma.

49. mTOR Signaling: Roles in Hepatitis B Virus Infection and Hepatocellular Carcinoma.

50. Effect of nucleos(t)ide analogue discontinuation on the prognosis of HBeAg-negative hepatitis B virus-related hepatocellular carcinoma after hepatectomy: A propensity score matching analysis.

Catalog

Books, media, physical & digital resources